Global Amlodipine Besylate Tablets Market Growth 2021-2026

Publisher Name :
Date: 20-Oct-2021
No. of pages: 101

According to this latest study, the 2021 growth of Amlodipine Besylate Tablets will have significant change from previous year. By the most conservative estimates of global Amlodipine Besylate Tablets market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Amlodipine Besylate Tablets market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Amlodipine Besylate Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- 5 Milligrams

- 10 Milligrams

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Hospital

- Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- China Resources Double-Crane Pharmaceutical

- Pfizer

- North China Pharmaceutical

- AstraZeneca

- Sanofi

- Roche

- Bristol-Myers Squibb

- Yangtze River Pharmaceutical

- Shanghai Shyndec Pharmaceutical

- Jingfeng Pharmaceutical

Global Amlodipine Besylate Tablets Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amlodipine Besylate Tablets Consumption 2016-2026
2.1.2 Amlodipine Besylate Tablets Consumption CAGR by Region
2.2 Amlodipine Besylate Tablets Segment by Type
2.2.1 5 Milligrams
2.2.2 10 Milligrams
2.3 Amlodipine Besylate Tablets Sales by Type
2.3.1 Global Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
2.3.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Type (2016-2021)
2.3.3 Global Amlodipine Besylate Tablets Sale Price by Type (2016-2021)
2.4 Amlodipine Besylate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amlodipine Besylate Tablets Sales by Application
2.5.1 Global Amlodipine Besylate Tablets Sale Market Share by Application (2016-2021)
2.5.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Application (2016-2021)
2.5.3 Global Amlodipine Besylate Tablets Sale Price by Application (2016-2021)

3 Global Amlodipine Besylate Tablets by Company
3.1 Global Amlodipine Besylate Tablets Sales Market Share by Company
3.1.1 Global Amlodipine Besylate Tablets Sales by Company (2019-2021)
3.1.2 Global Amlodipine Besylate Tablets Sales Market Share by Company (2019-2021)
3.2 Global Amlodipine Besylate Tablets Revenue Market Share by Company
3.2.1 Global Amlodipine Besylate Tablets Revenue by Company (2019-2021)
3.2.2 Global Amlodipine Besylate Tablets Revenue Market Share by Company (2019-2021)
3.3 Global Amlodipine Besylate Tablets Sale Price by Company
3.4 Global Manufacturers Amlodipine Besylate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amlodipine Besylate Tablets Product Location Distribution
3.4.2 Players Amlodipine Besylate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Amlodipine Besylate Tablets by Region
4.1 Global Amlodipine Besylate Tablets by Region
4.1.1 Global Amlodipine Besylate Tablets Sales by Region
4.1.2 Global Amlodipine Besylate Tablets Revenue by Region
4.2 Americas Amlodipine Besylate Tablets Sales Growth
4.3 APAC Amlodipine Besylate Tablets Sales Growth
4.4 Europe Amlodipine Besylate Tablets Sales Growth
4.5 Middle East & Africa Amlodipine Besylate Tablets Sales Growth

5 Americas
5.1 Americas Amlodipine Besylate Tablets Sales by Country
5.1.1 Americas Amlodipine Besylate Tablets Sales by Country (2016-2021)
5.1.2 Americas Amlodipine Besylate Tablets Revenue by Country (2016-2021)
5.2 Americas Amlodipine Besylate Tablets Sales by Type
5.3 Americas Amlodipine Besylate Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Amlodipine Besylate Tablets Sales by Region
6.1.1 APAC Amlodipine Besylate Tablets Sales by Region (2016-2021)
6.1.2 APAC Amlodipine Besylate Tablets Revenue by Region (2016-2021)
6.2 APAC Amlodipine Besylate Tablets Sales by Type
6.3 APAC Amlodipine Besylate Tablets Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Amlodipine Besylate Tablets by Country
7.1.1 Europe Amlodipine Besylate Tablets Sales by Country (2016-2021)
7.1.2 Europe Amlodipine Besylate Tablets Revenue by Country (2016-2021)
7.2 Europe Amlodipine Besylate Tablets Sales by Type
7.3 Europe Amlodipine Besylate Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Amlodipine Besylate Tablets by Country
8.1.1 Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2016-2021)
8.1.2 Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2016-2021)
8.2 Middle East & Africa Amlodipine Besylate Tablets Sales by Type
8.3 Middle East & Africa Amlodipine Besylate Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Amlodipine Besylate Tablets Distributors
10.3 Amlodipine Besylate Tablets Customer

11 Global Amlodipine Besylate Tablets Market Forecast
11.1 Global Amlodipine Besylate Tablets Forecast by Region
11.1.1 Global Amlodipine Besylate Tablets Forecast by Regions (2021-2026)
11.2.2 Global Amlodipine Besylate Tablets Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Amlodipine Besylate Tablets Forecast by Type
11.7 Global Amlodipine Besylate Tablets Forecast by Application

12 Key Players Analysis
12.1 China Resources Double-Crane Pharmaceutical
12.1.1 China Resources Double-Crane Pharmaceutical Company Information
12.1.2 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Offered
12.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 China Resources Double-Crane Pharmaceutical Main Business Overview
12.1.5 China Resources Double-Crane Pharmaceutical Latest Developments
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Amlodipine Besylate Tablets Product Offered
12.2.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Pfizer Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 North China Pharmaceutical
12.3.1 North China Pharmaceutical Company Information
12.3.2 North China Pharmaceutical Amlodipine Besylate Tablets Product Offered
12.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 North China Pharmaceutical Main Business Overview
12.3.5 North China Pharmaceutical Latest Developments
12.4 AstraZeneca
12.4.1 AstraZeneca Company Information
12.4.2 AstraZeneca Amlodipine Besylate Tablets Product Offered
12.4.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 AstraZeneca Main Business Overview
12.4.5 AstraZeneca Latest Developments
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi Amlodipine Besylate Tablets Product Offered
12.5.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Roche
12.6.1 Roche Company Information
12.6.2 Roche Amlodipine Besylate Tablets Product Offered
12.6.3 Roche Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Roche Main Business Overview
12.6.5 Roche Latest Developments
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Information
12.7.2 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Offered
12.7.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bristol-Myers Squibb Main Business Overview
12.7.5 Bristol-Myers Squibb Latest Developments
12.8 Yangtze River Pharmaceutical
12.8.1 Yangtze River Pharmaceutical Company Information
12.8.2 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Offered
12.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Yangtze River Pharmaceutical Main Business Overview
12.8.5 Yangtze River Pharmaceutical Latest Developments
12.9 Shanghai Shyndec Pharmaceutical
12.9.1 Shanghai Shyndec Pharmaceutical Company Information
12.9.2 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Offered
12.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
12.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
12.10 Jingfeng Pharmaceutical
12.10.1 Jingfeng Pharmaceutical Company Information
12.10.2 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Offered
12.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Jingfeng Pharmaceutical Main Business Overview
12.10.5 Jingfeng Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Amlodipine Besylate Tablets Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 5 Milligrams
Table 3. Major Players of 10 Milligrams
Table 4. Global Amlodipine Besylate Tablets Sales by Type (2016-2021) & (K Units)
Table 5. Global Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
Table 6. Global Amlodipine Besylate Tablets Revenue by Type (2016-2021) & ($ million)
Table 7. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2016-2021)
Table 8. Global Amlodipine Besylate Tablets Sale Price by Type (2016-2021)
Table 9. Global Amlodipine Besylate Tablets Sales by Application (2016-2021) & (K Units)
Table 10. Global Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Table 11. Global Amlodipine Besylate Tablets Value by Application (2016-2021)
Table 12. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2016-2021)
Table 13. Global Amlodipine Besylate Tablets Sale Price by Application (2016-2021)
Table 14. Global Amlodipine Besylate Tablets Sales by Company (2019-2021) & (K Units)
Table 15. Global Amlodipine Besylate Tablets Sales Market Share by Company (2019-2021)
Table 16. Global Amlodipine Besylate Tablets Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Amlodipine Besylate Tablets Revenue Market Share by Company (2019-2021)
Table 18. Global Amlodipine Besylate Tablets Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Amlodipine Besylate Tablets Producing Area Distribution and Sales Area
Table 20. Players Amlodipine Besylate Tablets Products Offered
Table 21. Amlodipine Besylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Amlodipine Besylate Tablets Sales by Region (2016-2021) (K Units)
Table 25. Global Amlodipine Besylate Tablets Sales Market Share by Region (2016-2021)
Table 26. Global Amlodipine Besylate Tablets Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2016-2021)
Table 28. Americas Amlodipine Besylate Tablets Sales by Country (2016-2021) & (K Units)
Table 29. Americas Amlodipine Besylate Tablets Sales Market Share by Country (2016-2021)
Table 30. Americas Amlodipine Besylate Tablets Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Amlodipine Besylate Tablets Revenue Market Share by Country (2016-2021)
Table 32. Americas Amlodipine Besylate Tablets Sales by Type (2016-2021) & (K Units)
Table 33. Americas Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
Table 34. Americas Amlodipine Besylate Tablets Sales by Application (2016-2021) & (K Units)
Table 35. Americas Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Table 36. APAC Amlodipine Besylate Tablets Sales by Region (2016-2021) & (K Units)
Table 37. APAC Amlodipine Besylate Tablets Sales Market Share by Region (2016-2021)
Table 38. APAC Amlodipine Besylate Tablets Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Amlodipine Besylate Tablets Revenue Market Share by Region (2016-2021)
Table 40. APAC Amlodipine Besylate Tablets Sales by Type (2016-2021) & (K Units)
Table 41. APAC Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
Table 42. APAC Amlodipine Besylate Tablets Sales by Application (2016-2021) & (K Units)
Table 43. APAC Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Table 44. Europe Amlodipine Besylate Tablets Sales by Country (2016-2021) & (K Units)
Table 45. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2016-2021)
Table 46. Europe Amlodipine Besylate Tablets Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Amlodipine Besylate Tablets Revenue Market Share by Country (2016-2021)
Table 48. Europe Amlodipine Besylate Tablets Sales by Type (2016-2021) & (K Units)
Table 49. Europe Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
Table 50. Europe Amlodipine Besylate Tablets Sales by Application (2016-2021) & (K Units)
Table 51. Europe Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Amlodipine Besylate Tablets Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Amlodipine Besylate Tablets Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Amlodipine Besylate Tablets
Table 61. Key Application and Potential Industries of Amlodipine Besylate Tablets
Table 62. Key Challenges of Amlodipine Besylate Tablets
Table 63. Key Trends of Amlodipine Besylate Tablets
Table 64. Amlodipine Besylate Tablets Distributors List
Table 65. Amlodipine Besylate Tablets Customer List
Table 66. Global Amlodipine Besylate Tablets Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Amlodipine Besylate Tablets Consumption Market Forecast by Region
Table 68. Global Amlodipine Besylate Tablets Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Amlodipine Besylate Tablets Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Amlodipine Besylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Amlodipine Besylate Tablets Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Amlodipine Besylate Tablets Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Amlodipine Besylate Tablets Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Amlodipine Besylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Amlodipine Besylate Tablets Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Amlodipine Besylate Tablets Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Amlodipine Besylate Tablets Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Amlodipine Besylate Tablets Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Amlodipine Besylate Tablets Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Amlodipine Besylate Tablets Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Application (2021-2026)
Table 86. China Resources Double-Crane Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 87. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Offered
Table 88. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. China Resources Double-Crane Pharmaceutical Main Business
Table 90. China Resources Double-Crane Pharmaceutical Latest Developments
Table 91. Pfizer Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Amlodipine Besylate Tablets Product Offered
Table 93. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. North China Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 97. North China Pharmaceutical Amlodipine Besylate Tablets Product Offered
Table 98. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. North China Pharmaceutical Main Business
Table 100. North China Pharmaceutical Latest Developments
Table 101. AstraZeneca Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca Amlodipine Besylate Tablets Product Offered
Table 103. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. Sanofi Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi Amlodipine Besylate Tablets Product Offered
Table 108. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Sanofi Main Business
Table 110. Sanofi Latest Developments
Table 111. Roche Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 112. Roche Amlodipine Besylate Tablets Product Offered
Table 113. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Roche Main Business
Table 115. Roche Latest Developments
Table 116. Bristol-Myers Squibb Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 117. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Offered
Table 118. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Bristol-Myers Squibb Main Business
Table 120. Bristol-Myers Squibb Latest Developments
Table 121. Yangtze River Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 122. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Offered
Table 123. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Yangtze River Pharmaceutical Main Business
Table 125. Yangtze River Pharmaceutical Latest Developments
Table 126. Shanghai Shyndec Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Offered
Table 128. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Shanghai Shyndec Pharmaceutical Main Business
Table 130. Shanghai Shyndec Pharmaceutical Latest Developments
Table 131. Jingfeng Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 132. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Offered
Table 133. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Jingfeng Pharmaceutical Main Business
Table 135. Jingfeng Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Amlodipine Besylate Tablets
Figure 2. Amlodipine Besylate Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amlodipine Besylate Tablets Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Amlodipine Besylate Tablets Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Amlodipine Besylate Tablets Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 5 Milligrams
Figure 10. Product Picture of 10 Milligrams
Figure 11. Global Amlodipine Besylate Tablets Sales Market Share by Type in 2020
Figure 12. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2016-2021)
Figure 13. Amlodipine Besylate Tablets Consumed in Hospital
Figure 14. Global Amlodipine Besylate Tablets Market: Hospital (2016-2021) & (K Units)
Figure 15. Amlodipine Besylate Tablets Consumed in Pharmacy
Figure 16. Global Amlodipine Besylate Tablets Market: Pharmacy (2016-2021) & (K Units)
Figure 17. Global Amlodipine Besylate Tablets Sales Market Share by Application (2016-2021)
Figure 18. Global Amlodipine Besylate Tablets Revenue Market Share by Application in 2020
Figure 19. Amlodipine Besylate Tablets Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Amlodipine Besylate Tablets Revenue Market Share by Company in 2020
Figure 21. Global Amlodipine Besylate Tablets Sales Market Share by Regions (2016-2021)
Figure 22. Global Amlodipine Besylate Tablets Revenue Market Share by Region in 2020
Figure 23. Americas Amlodipine Besylate Tablets Sales 2016-2021 (K Units)
Figure 24. Americas Amlodipine Besylate Tablets Revenue 2016-2021 ($ Millions)
Figure 25. APAC Amlodipine Besylate Tablets Sales 2016-2021 (K Units)
Figure 26. APAC Amlodipine Besylate Tablets Revenue 2016-2021 ($ Millions)
Figure 27. Europe Amlodipine Besylate Tablets Sales 2016-2021 (K Units)
Figure 28. Europe Amlodipine Besylate Tablets Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Amlodipine Besylate Tablets Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Amlodipine Besylate Tablets Revenue 2016-2021 ($ Millions)
Figure 31. Americas Amlodipine Besylate Tablets Sales Market Share by Country in 2020
Figure 32. Americas Amlodipine Besylate Tablets Revenue Market Share by Country in 2020
Figure 33. Americas Amlodipine Besylate Tablets Sales Market Share by Type in 2020
Figure 34. Americas Amlodipine Besylate Tablets Sales Market Share by Application in 2020
Figure 35. United States Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Amlodipine Besylate Tablets Sales Market Share by Region in 2020
Figure 40. APAC Amlodipine Besylate Tablets Revenue Market Share by Regions in 2020
Figure 41. APAC Amlodipine Besylate Tablets Sales Market Share by Type in 2020
Figure 42. APAC Amlodipine Besylate Tablets Sales Market Share by Application in 2020
Figure 43. China Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Amlodipine Besylate Tablets Sales Market Share by Country in 2020
Figure 50. Europe Amlodipine Besylate Tablets Revenue Market Share by Country in 2020
Figure 51. Europe Amlodipine Besylate Tablets Sales Market Share by Type in 2020
Figure 52. Europe Amlodipine Besylate Tablets Sales Market Share by Application in 2020
Figure 53. Germany Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Application in 2020
Figure 62. Egypt Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Amlodipine Besylate Tablets Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs